
Zeria Pharmaceutical Co., Ltd.
4559.TJPXHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
¥2,122
−¥31.00 · -1.44%
4559.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteZeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company also offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn’s disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia, and iron deficiency anemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; and non-steroidal anti-inflammatory ophthalmic solutions. In addition, it provides consumer healthcare products, such as nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicines, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses. Further, the company engages in insurance agency and real estate business. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was incorporated in 1955 and is headquartered in Tokyo, Japan.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Sachiaki Ibe
- Listed since
- Jan 1, 2001
- Employees
- 1,748
Market position
Day range
Current ¥2,122
52-week range
Current ¥2,122
- Open
- ¥2,156
- Previous close
- ¥2,153
- Volume
- 72.9K
- 0.77× average
- Average volume
- 94.78K
- Average daily volume
- Market cap
- 93.54B JPY
- Beta
- 0.06
- Market reference 1
- 50-day average
- ¥2,078.32
- +2.10% above average
- 200-day average
- ¥2,126.89
- -0.23% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 108.1B JPY
- P/E (TTM)
- 11.37×
- P/B (TTM)
- 0.87×
- P/S (TTM)
- 1.03×
- EV / EBITDA
- 5.48×
- Earnings yield
- 8.74%
- Free cash flow yield
- 7.85%
- Dividend yield
- 2.31%
Profitability & efficiency
- Gross margin
- 72.99%
- Operating margin
- 14.05%
- Net margin
- 9.03%
- Return on equity
- 7.80%
- Return on assets
- 4.70%
- Return on invested capital
- 5.89%
Financial health
- Debt / equity
- 0.34×
- Current ratio
- 1.48×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 89.16B JPY | 87.31B JPY | 75.73B JPY | 68.38B JPY | 59.53B JPY |
| Cost of goods sold | 23.98B JPY | 29.2B JPY | 25.54B JPY | 23.27B JPY | 17.38B JPY |
| Gross profit | 65.18B JPY | 58.11B JPY | 50.18B JPY | 45.12B JPY | 42.15B JPY |
| Research and development | — | 4.11B JPY | 3.73B JPY | 3.46B JPY | 4.79B JPY |
| Selling, general, and administrative | 52.81B JPY | 41.81B JPY | 36.74B JPY | 32.65B JPY | 30.99B JPY |
| Operating expenses | 52.81B JPY | 45.91B JPY | 40.46B JPY | 36.1B JPY | 35.78B JPY |
| Interest income | 111.81M JPY | 282.87M JPY | 150.94M JPY | 67.89M JPY | 17.24M JPY |
| Interest expense | 501.8M JPY | 452.29M JPY | 457.8M JPY | 337.28M JPY | 315.46M JPY |
| Depreciation and amortization | 7.35B JPY | 7.55B JPY | 7.56B JPY | 6.15B JPY | 5.4B JPY |
| Operating income | 12.37B JPY | 12.2B JPY | 9.72B JPY | 9.01B JPY | 6.37B JPY |
| Net income | 8.45B JPY | 9.94B JPY | 7.73B JPY | 6.2B JPY | 3.96B JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 19.65
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
4559.T peers
ETFs holding 4559.T
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T162.98M0.01%2.89T JPY0.05%¥418.2+0.05%
Vanguard Total International Stock ETFVXUS5.84M0.00%646.2B USD0.05%$87.71+0.78%
Vanguard FTSE Developed Markets ETFVEA3.65M0.00%315B USD0.03%$73.42+0.80%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS1.39M0.01%13.6B USD0.06%$160.06+0.43%
WisdomTree Japan Hedged Equity FundDXJ1.24M0.02%7.11B USD0.48%$177.54+1.10%
iShares MSCI EAFE Small-Cap ETFSCZ1.13M0.01%13.28B USD0.40%$86.60+0.70%
Schwab International Small-Cap Equity ETFSCHC806.97K0.01%5.73B USD0.06%$51.25+0.61%
Avantis International Equity ETFAVDE569.62K—19.1B USD0.23%$94.26+0.87%
iShares Core TOPIX ETF1475.T- Market value
- 162.98M
- Weight
- 0.01%
- AUM
- 2.89T JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥418.2+0.05%
Vanguard Total International Stock ETFVXUS- Market value
- 5.84M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.71+0.78%
Vanguard FTSE Developed Markets ETFVEA- Market value
- 3.65M
- Weight
- 0.00%
- AUM
- 315B USD
- Expense ratio
- 0.03%
- Price / 1D
- $73.42+0.80%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS- Market value
- 1.39M
- Weight
- 0.01%
- AUM
- 13.6B USD
- Expense ratio
- 0.06%
- Price / 1D
- $160.06+0.43%
WisdomTree Japan Hedged Equity FundDXJ- Market value
- 1.24M
- Weight
- 0.02%
- AUM
- 7.11B USD
- Expense ratio
- 0.48%
- Price / 1D
- $177.54+1.10%
iShares MSCI EAFE Small-Cap ETFSCZ- Market value
- 1.13M
- Weight
- 0.01%
- AUM
- 13.28B USD
- Expense ratio
- 0.40%
- Price / 1D
- $86.60+0.70%
Schwab International Small-Cap Equity ETFSCHC- Market value
- 806.97K
- Weight
- 0.01%
- AUM
- 5.73B USD
- Expense ratio
- 0.06%
- Price / 1D
- $51.25+0.61%
Avantis International Equity ETFAVDE- Market value
- 569.62K
- Weight
- —
- AUM
- 19.1B USD
- Expense ratio
- 0.23%
- Price / 1D
- $94.26+0.87%
Continue in GoAI
Research 4559.Tresearch.disclaimer





